Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone
Open Access
- 10 August 2012
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 83 (4), 411-419
- https://doi.org/10.3109/17453674.2012.702388
Abstract
Intermittent administration of parathyroid hormone (PTH) has an anabolic effect on bone, as confirmed in human osteoporosis studies, distraction osteogenesis, and fracture healing. PTH in rat models leads to improved fixation of implants in low-density bone or screw insertion transcortically. We examined the effect of human PTH (1-34) on the cancellous osseointegration of unloaded implants inserted press-fit in intact bone of higher animal species. 20 dogs were randomized to treatment with human PTH (1-34), 5 μg/kg/day subcutaneously, or placebo for 4 weeks starting on the day after insertion of a cylindrical porous coated plasma-sprayed titanium alloy implant in the proximal metaphyseal cancellous bone of tibia. Osseointegration was evaluated by histomorphometry and fixation by push-out test to failure. Surface fraction of woven bone at the implant interface was statistically significantly higher in the PTH group by 1.4 fold with (median (interquartile range) 15% (13-18)) in the PTH group and 11% (7-13) in control. The fraction of lamellar bone was unaltered. No significant difference in bone or fibrous tissue was observed in the circumferential regions of 0-500, 500-1,000, and 1,000-2,000 μm around the implant. Mechanically, the implants treated with PTH showed no significant differences in total energy absorption, maximum shear stiffness, or maximum shear strength. Intermittent treatment with PTH (1-34) improved histological osseointegration of a prosthesis inserted press-fit at surgery in cancellous bone, with no additional improvement of the initial mechanical fixation at this time point.Keywords
This publication has 56 references indexed in Scilit:
- Parathyroid hormone PTH(1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbitsActa Orthopaedica, 2009
- Intermittent administration of human parathyroid hormone (1–34) increases new bone formation on the interface of hydroxyapatitecoated titanium rods implanted into ovariectomized rat femoraJournal of Orthopaedic Science, 2008
- Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblastsBone, 2008
- Defective Implant Osseointegration Under Protein Undernutrition: Prevention by PTH or PamidronateJournal of Bone and Mineral Research, 2007
- Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical boneJournal of Bone and Mineral Research, 1996
- PTH: A future role in the management of osteoporosis?Journal of Bone and Mineral Research, 1996
- Parathyroid hormone (1–34) increases vertebral bone mass, compressive strength, and quality in old ratsBone, 1995
- Effect of treatment for 3 months with human parathyroid hormone 1–34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).Bone, 1995
- Animal models of cortical porosityBone, 1995
- A Method for Preparing and Staining Histological Sections Containing Titanium Implants for Light MicroscopyStain Technology, 1989